AstraZeneca nears top of FTSE 100 leader board after trials shows cancer risk cut
Investors followed upbeat drugs data from pharmaceutical giant AstraZeneca (AZN) pushing the stock towards the top of the FTSE 100 leader board on Tuesday (15 February 2022).Astra reported positive results from Phase III trials of...
15 February 2022